INGLIS TIFFANY EUL DAVIS (Chief Medical Officer) received a stock award from SERA PROGNOSTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/15/2025ACC: 0001193125-25-240530
Officer· Chief Medical Officer
Since Mar 2026
+182K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
182K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
New position
10/15/2025
0.00→75K
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 10/15/2025 | A · Award | +75K | — | — | New position | 0.00 | 75K |
| Total | +75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
107K shares
Shares
+107K
Strike price
3.13
Held after
107K
Exercisable
—
10/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock107K shares | 10/15/2025 | A · Award | +107K | 3.13 | — | 107K |